Rachel Waddell
Family · Rapid City, SDNPI 1164734646
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,023, more than ten times the $16 reported in 2021. Among family clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$661
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$422
- AbbVie$421
- Harmony Biosciences LLC$283
- Otsuka America Pharmaceutical, Inc.$251
- Lundbeck LLC$233
- plus $891 from 11 others
What the payments were for
- Food & beverage$3,160100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 20 | $661 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $422 |
| AbbVie | 19 | $421 |
| Harmony Biosciences LLC | 15 | $283 |
| Otsuka America Pharmaceutical, Inc. | 8 | $251 |
| Lundbeck LLC | 12 | $233 |
| Teva Pharmaceuticals USA, Inc. | 8 | $178 |
| Axsome Therapeutics, Inc. | 6 | $136 |
| Bayer | 1 | $125 |
| Neurocrine Biosciences, Inc. | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Ironshore Pharmaceuticals Inc. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Corium, LLC | 1 | $34 |
| Merck | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,418
- Kerendia$125
- ABILIFY MAINTENA$124
- ABILIFY ASIMTUFII$124
How this compares
$3,160 in reported general payments places this provider in the 90th percentile of 588 family providers in South Dakota.
Other family in Rapid City
- Claudia HouglandRapid City$9K
- Melissa OwensRapid City$6K
- Kristen DirksRapid City$5K
- Janessa HuntRapid City$5K
- Rebecca ChristensenRapid City$5K
- Jamie SlettedahlRapid City$4K
- Kristy SchumacherRapid City$4K
- Vanessa PribilRapid City$3K
- Kelsey JohnsonRapid City$3K
- Melissa TraubRapid City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.